155 related articles for article (PubMed ID: 6421932)
1. Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interface.
Redelman D; Bluestein HG; Cohen AH; Depper JM; Wormsley S
J Immunol; 1984 Apr; 132(4):2030-8. PubMed ID: 6421932
[TBL] [Abstract][Full Text] [Related]
2. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
Ruers TJ; Buurman WA; van der Linden CJ
J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141
[TBL] [Abstract][Full Text] [Related]
3. Deoxyadenosine modulates human suppressor T cell function and B cell differentiation stimulated by Staphylococcus aureus protein A.
Cohen AH; Bluestein HG; Redelman D
J Immunol; 1984 Apr; 132(4):1761-6. PubMed ID: 6199411
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
Matsumoto SS; Yu J; Yu AL
J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation.
Bettens F; Kristensen F; Walker C; Schwuléra U; Bonnard GD; de Weck AL
J Immunol; 1984 Jan; 132(1):261-5. PubMed ID: 6606667
[TBL] [Abstract][Full Text] [Related]
7. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
[TBL] [Abstract][Full Text] [Related]
9. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis.
Rigby WF; Noelle RJ; Krause K; Fanger MW
J Immunol; 1985 Oct; 135(4):2279-86. PubMed ID: 2993410
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
Lillehoj HS; Malek TR; Shevach EM
J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
[TBL] [Abstract][Full Text] [Related]
11. T cell growth factor required for optimal induction of T cell growth factor receptor expression in phytohemagglutinin-stimulated T cells.
Reeves WG; Zamkoff KW; Poiesz BJ; Paolozzi FP; Tomar RH; Moore JL; Ruscetti FW
J Biol Response Mod; 1985 Feb; 4(1):83-95. PubMed ID: 2984341
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
[TBL] [Abstract][Full Text] [Related]
13. Selective effects of interferon on distinct sites of the T lymphocyte triggering process.
Leanderson T; Hillörn V; Holmberg D; Larsson EL; Lundgren E
J Immunol; 1982 Aug; 129(2):490-4. PubMed ID: 6177767
[TBL] [Abstract][Full Text] [Related]
14. Functional significance of Tac antigen expressed on activated human T lymphocytes: Tac antigen interacts with T cell growth factor in cellular proliferation.
Miyawaki T; Yachie A; Uwadana N; Ohzeki S; Nagaoki T; Taniguchi N
J Immunol; 1982 Dec; 129(6):2474-8. PubMed ID: 6982926
[TBL] [Abstract][Full Text] [Related]
15. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
Veit BC; Fishman M; Look T
J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
[TBL] [Abstract][Full Text] [Related]
16. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
17. Differential production of deoxyadenosine by human T and B lymphoblasts.
Iizasa T; Kubota M; Carson DA
J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
19. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
Walker C; Kristensen F; Bettens F; deWeck AL
J Immunol; 1983 Apr; 130(4):1770-3. PubMed ID: 6601136
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the expression of Tac antigen (T-cell growth factor response) on human thymocytes.
Yeh NH; Dipre M; Reem GH
Thymus; 1984; 6(4):255-61. PubMed ID: 6437022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
